Clinical Trial Update: Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women (0773-003) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, and preliminary efficacy of MK0773 in postmenopausal women with osteoporosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• MK0773

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED